FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula I, or a pharmaceutically acceptable salt thereof. In formula IRa is hydrogen; Rb is -SO2R1; R2 is hydrogen; Rc is hydrogen; m is selected from 0, 1 and 2; R3 is hydrogen; R4 is hydrogen; R5 and R6 are hydrogen; R7 is unsubstituted -C1-C8 alkyl; values of other radicals are given in the patent claim. Invention also relates to individual compounds, to a method for preventing or treating an FXR-mediated disease or condition in a subject in need thereof, to a pharmaceutical composition.
EFFECT: technical result is obtaining novel compounds of formula I, having FXR modulator properties.
24 cl, 9 tbl, 218 ex
Title | Year | Author | Number |
---|---|---|---|
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS FOR USE THEREOF | 2015 |
|
RU2707280C2 |
METHOD FOR PREPARING SULFONYLCARBAMATE BILE ACID DERIVATIVES | 2018 |
|
RU2791682C2 |
QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | 2008 |
|
RU2493160C2 |
HEPATITIS C VIRUS INHIBITORS | 2010 |
|
RU2544010C2 |
DIAZONIUM AMIDE ANALOGUES | 2012 |
|
RU2608308C2 |
TETRAZOLE-CONTAINING INHIBITORS OF APOPTOTIC SIGNAL-REGULATING KINASE 1 AND METHODS OF THEIR USE | 2019 |
|
RU2807545C2 |
MEK INHIBITORS AND THEIR THERAPEUTIC USE | 2021 |
|
RU2812929C1 |
NEUROACTIVE STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2808166C2 |
19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | 2014 |
|
RU2675855C2 |
NEUROACTIVE STEROIDS AND METHODS FOR USE THEREOF | 2014 |
|
RU2684103C2 |
Authors
Dates
2020-01-24—Published
2016-03-30—Filed